/RASP
RASP Stock - Actavia Life Sciences, Inc.
Healthcare|BiotechnologyOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for RASP
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-64.36
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | $-314 | $-1,635 | $-3,471 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-4,238,000 | $141,088 | $-248,000 | $-5,429,000 | $-915,170 |
| Net Income | $-4,443,000 | $-687,000 | $-876,000 | $-5,347,000 | $-936,380 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.01 | $-0.01 | $-0.01 | $-0.08 | $-0.01 |
Company Overview
Actavia Life Sciences, Inc. is a biotechnology company, which engages in the development of therapeutics for the treatment of leukemia and lymphoma diseases. It also develops small molecule drug candidates that focus on treating acute myeloid leukemia. The company was founded in 2013 and is headquartered in New York, NY.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
RASPBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q2 2024
EPS Surprise History
Q3 22
No data
Q1 23
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q1 24
No data
Q1 24
No data
Q2 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Jun 23, 2025 | — | — | — | — |
Q2 2025 | May 30, 2025 | — | — | — | — |
Q1 2025 | Feb 28, 2025 | — | — | — | — |
Q4 2024 | Nov 22, 2024 | — | — | — | — |
Q3 2024 | Aug 30, 2024 | — | — | — | — |
Q2 2024 | May 20, 2024 | — | $-0.00 | — | — |
Q1 2024 | Feb 16, 2024 | — | $-0.00 | — | — |
Q1 2024 | Jan 5, 2024 | — | $-0.00 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 15, 2023 | — | $-0.01 | — | — |
Q1 2023 | Mar 2, 2023 | — | $-0.00 | — | — |
Q1 2023 | Feb 9, 2023 | — | $-0.00 | — | — |
Q3 2022 | Aug 22, 2022 | — | $-0.01 | — | — |
Q2 2022 | Jun 21, 2022 | — | $0.00 | — | — |
Q2 2022 | Jun 16, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 1, 2022 | — | $-0.00 | — | — |
Q3 2021 | Aug 16, 2021 | — | $-0.00 | — | — |
Q2 2021 | Jun 2, 2021 | — | $-0.00 | — | — |
Q2 2021 | Apr 5, 2021 | — | $-0.00 | — | — |
Q1 2021 | Jan 15, 2021 | — | $-0.03 | — | — |
Latest News
Loading news...
Frequently Asked Questions about RASP
What is RASP's current stock price?
Actavia Life Sciences, Inc. (RASP) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for RASP?
No analyst price targets are currently available for this stock.
What sector is Actavia Life Sciences, Inc. in?
Actavia Life Sciences, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is RASP's market cap?
Actavia Life Sciences, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does RASP pay dividends?
No, Actavia Life Sciences, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCHNXF
ChitogenX Inc.
$0.01
Mkt Cap: $0.0B
IPIX
Innovation Pharmaceuticals Inc.
$0.00
Mkt Cap: $0.0B
LFCOF
Lift & Co. Corp.
$0.00
Mkt Cap: $0.0B
MDIN
MedGen, Inc.
$0.00
Mkt Cap: $0.0B
NBIO
Nascent Biotech, Inc.
$0.00
Mkt Cap: $0.0B
PDMI
Paradigm Medical Industries, Inc.
$0.00
Mkt Cap: $0.0B
RSPI
RespireRx Pharmaceuticals Inc.
$0.00
Mkt Cap: $0.0B
TEVNF
Tevano Systems Holdings Inc.
$0.00
Mkt Cap: $0.0B
VIRX
Viracta Therapeutics, Inc.
$0.01
Mkt Cap: $0.0B
WSNAF
Wesana Health Holdings Inc.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to RASP for comparison